The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Orally Disintegrating Tablet Excipient Market Research Report 2025
Synopsis
The global market for Orally Disintegrating Tablet Excipient was valued at US$ 17830 million in the year 2024 and is projected to reach a revised size of US$ 22600 million by 2031, growing at a CAGR of 3.5% during the forecast period.
An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications.An excipient is a pharmacologically inert adhesive substance used to bind the contents of a pill or tablet. This type of tablet separates in the mouth in contact with saliva, making it easy for a person to swallow the tablet without drinking water.
McePharma (Vivesa holding) was the global greatest company in Orally Disintegrating Tablet Excipient industry, with the revenue market Share of 3% , followed by BASF, JRS Pharma, Roquette, ABF Ingredients, DFE Pharma, Evonik, Merck KGaA, Ashland, Meggle Pharma, Shin-Etsu, Fuji Chemical Industries, Cargill Incorporated, Daicel Corporation, Anhui Sunhere Pharmaceutical.APAC is the largest Orally Disintegrating Tablet Excipient market with about 30% market share. Americas is follower, accounting for about 27% market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Orally Disintegrating Tablet Excipient, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Orally Disintegrating Tablet Excipient.
The Orally Disintegrating Tablet Excipient market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Orally Disintegrating Tablet Excipient market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Orally Disintegrating Tablet Excipient manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
BASF
JRS Pharma
Roquette
ABF Ingredients
DFE Pharma
Evonik
Merck KGaA
Ashland
Meggle Pharma
Shin-Etsu
Fuji Chemical Industries
McePharma (Vivesa holding)
Cargill Incorporated
Daicel Corporation
Anhui Sunhere Pharmaceutical
Segment by Type
Binders
Glidents
Diluents
Disintegrants
Others
Segment by Application
Anti-Psychotics Drug
Anti-Epileptics Drug
Others
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Orally Disintegrating Tablet Excipient manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Orally Disintegrating Tablet Excipient in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global market for Orally Disintegrating Tablet Excipient was valued at US$ 17830 million in the year 2024 and is projected to reach a revised size of US$ 22600 million by 2031, growing at a CAGR of 3.5% during the forecast period.
An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications.An excipient is a pharmacologically inert adhesive substance used to bind the contents of a pill or tablet. This type of tablet separates in the mouth in contact with saliva, making it easy for a person to swallow the tablet without drinking water.
McePharma (Vivesa holding) was the global greatest company in Orally Disintegrating Tablet Excipient industry, with the revenue market Share of 3% , followed by BASF, JRS Pharma, Roquette, ABF Ingredients, DFE Pharma, Evonik, Merck KGaA, Ashland, Meggle Pharma, Shin-Etsu, Fuji Chemical Industries, Cargill Incorporated, Daicel Corporation, Anhui Sunhere Pharmaceutical.APAC is the largest Orally Disintegrating Tablet Excipient market with about 30% market share. Americas is follower, accounting for about 27% market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Orally Disintegrating Tablet Excipient, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Orally Disintegrating Tablet Excipient.
The Orally Disintegrating Tablet Excipient market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Orally Disintegrating Tablet Excipient market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Orally Disintegrating Tablet Excipient manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
BASF
JRS Pharma
Roquette
ABF Ingredients
DFE Pharma
Evonik
Merck KGaA
Ashland
Meggle Pharma
Shin-Etsu
Fuji Chemical Industries
McePharma (Vivesa holding)
Cargill Incorporated
Daicel Corporation
Anhui Sunhere Pharmaceutical
Segment by Type
Binders
Glidents
Diluents
Disintegrants
Others
Segment by Application
Anti-Psychotics Drug
Anti-Epileptics Drug
Others
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Orally Disintegrating Tablet Excipient manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Orally Disintegrating Tablet Excipient in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Orally Disintegrating Tablet Excipient Market Overview
1.1 Product Definition
1.2 Orally Disintegrating Tablet Excipient by Type
1.2.1 Global Orally Disintegrating Tablet Excipient Market Value Comparison by Type (2024 VS 2031)
1.2.2 Binders
1.2.3 Glidents
1.2.4 Diluents
1.2.5 Disintegrants
1.2.6 Others
1.3 Orally Disintegrating Tablet Excipient by Application
1.3.1 Global Orally Disintegrating Tablet Excipient Market Value by Application (2024 VS 2031)
1.3.2 Anti-Psychotics Drug
1.3.3 Anti-Epileptics Drug
1.3.4 Others
1.4 Global Orally Disintegrating Tablet Excipient Market Size Estimates and Forecasts
1.4.1 Global Orally Disintegrating Tablet Excipient Revenue 2020-2031
1.4.2 Global Orally Disintegrating Tablet Excipient Sales 2020-2031
1.4.3 Global Orally Disintegrating Tablet Excipient Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Orally Disintegrating Tablet Excipient Market Competition by Manufacturers
2.1 Global Orally Disintegrating Tablet Excipient Sales Market Share by Manufacturers (2020-2025)
2.2 Global Orally Disintegrating Tablet Excipient Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Orally Disintegrating Tablet Excipient Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Orally Disintegrating Tablet Excipient, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Orally Disintegrating Tablet Excipient, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Orally Disintegrating Tablet Excipient, Product Type & Application
2.7 Global Key Manufacturers of Orally Disintegrating Tablet Excipient, Date of Enter into This Industry
2.8 Global Orally Disintegrating Tablet Excipient Market Competitive Situation and Trends
2.8.1 Global Orally Disintegrating Tablet Excipient Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Orally Disintegrating Tablet Excipient Players Market Share by Revenue
2.8.3 Global Orally Disintegrating Tablet Excipient Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Orally Disintegrating Tablet Excipient Market Scenario by Region
3.1 Global Orally Disintegrating Tablet Excipient Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Orally Disintegrating Tablet Excipient Sales by Region: 2020-2031
3.2.1 Global Orally Disintegrating Tablet Excipient Sales by Region: 2020-2025
3.2.2 Global Orally Disintegrating Tablet Excipient Sales by Region: 2026-2031
3.3 Global Orally Disintegrating Tablet Excipient Revenue by Region: 2020-2031
3.3.1 Global Orally Disintegrating Tablet Excipient Revenue by Region: 2020-2025
3.3.2 Global Orally Disintegrating Tablet Excipient Revenue by Region: 2026-2031
3.4 North America Orally Disintegrating Tablet Excipient Market Facts & Figures by Country
3.4.1 North America Orally Disintegrating Tablet Excipient Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Orally Disintegrating Tablet Excipient Sales by Country (2020-2031)
3.4.3 North America Orally Disintegrating Tablet Excipient Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Orally Disintegrating Tablet Excipient Market Facts & Figures by Country
3.5.1 Europe Orally Disintegrating Tablet Excipient Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Orally Disintegrating Tablet Excipient Sales by Country (2020-2031)
3.5.3 Europe Orally Disintegrating Tablet Excipient Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Orally Disintegrating Tablet Excipient Market Facts & Figures by Region
3.6.1 Asia Pacific Orally Disintegrating Tablet Excipient Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Orally Disintegrating Tablet Excipient Sales by Region (2020-2031)
3.6.3 Asia Pacific Orally Disintegrating Tablet Excipient Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Orally Disintegrating Tablet Excipient Market Facts & Figures by Country
3.7.1 Latin America Orally Disintegrating Tablet Excipient Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Orally Disintegrating Tablet Excipient Sales by Country (2020-2031)
3.7.3 Latin America Orally Disintegrating Tablet Excipient Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Orally Disintegrating Tablet Excipient Market Facts & Figures by Country
3.8.1 Middle East and Africa Orally Disintegrating Tablet Excipient Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Orally Disintegrating Tablet Excipient Sales by Country (2020-2031)
3.8.3 Middle East and Africa Orally Disintegrating Tablet Excipient Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Orally Disintegrating Tablet Excipient Sales by Type (2020-2031)
4.1.1 Global Orally Disintegrating Tablet Excipient Sales by Type (2020-2025)
4.1.2 Global Orally Disintegrating Tablet Excipient Sales by Type (2026-2031)
4.1.3 Global Orally Disintegrating Tablet Excipient Sales Market Share by Type (2020-2031)
4.2 Global Orally Disintegrating Tablet Excipient Revenue by Type (2020-2031)
4.2.1 Global Orally Disintegrating Tablet Excipient Revenue by Type (2020-2025)
4.2.2 Global Orally Disintegrating Tablet Excipient Revenue by Type (2026-2031)
4.2.3 Global Orally Disintegrating Tablet Excipient Revenue Market Share by Type (2020-2031)
4.3 Global Orally Disintegrating Tablet Excipient Price by Type (2020-2031)
5 Segment by Application
5.1 Global Orally Disintegrating Tablet Excipient Sales by Application (2020-2031)
5.1.1 Global Orally Disintegrating Tablet Excipient Sales by Application (2020-2025)
5.1.2 Global Orally Disintegrating Tablet Excipient Sales by Application (2026-2031)
5.1.3 Global Orally Disintegrating Tablet Excipient Sales Market Share by Application (2020-2031)
5.2 Global Orally Disintegrating Tablet Excipient Revenue by Application (2020-2031)
5.2.1 Global Orally Disintegrating Tablet Excipient Revenue by Application (2020-2025)
5.2.2 Global Orally Disintegrating Tablet Excipient Revenue by Application (2026-2031)
5.2.3 Global Orally Disintegrating Tablet Excipient Revenue Market Share by Application (2020-2031)
5.3 Global Orally Disintegrating Tablet Excipient Price by Application (2020-2031)
6 Key Companies Profiled
6.1 BASF
6.1.1 BASF Company Information
6.1.2 BASF Description and Business Overview
6.1.3 BASF Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2020-2025)
6.1.4 BASF Orally Disintegrating Tablet Excipient Product Portfolio
6.1.5 BASF Recent Developments/Updates
6.2 JRS Pharma
6.2.1 JRS Pharma Company Information
6.2.2 JRS Pharma Description and Business Overview
6.2.3 JRS Pharma Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2020-2025)
6.2.4 JRS Pharma Orally Disintegrating Tablet Excipient Product Portfolio
6.2.5 JRS Pharma Recent Developments/Updates
6.3 Roquette
6.3.1 Roquette Company Information
6.3.2 Roquette Description and Business Overview
6.3.3 Roquette Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Roquette Orally Disintegrating Tablet Excipient Product Portfolio
6.3.5 Roquette Recent Developments/Updates
6.4 ABF Ingredients
6.4.1 ABF Ingredients Company Information
6.4.2 ABF Ingredients Description and Business Overview
6.4.3 ABF Ingredients Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2020-2025)
6.4.4 ABF Ingredients Orally Disintegrating Tablet Excipient Product Portfolio
6.4.5 ABF Ingredients Recent Developments/Updates
6.5 DFE Pharma
6.5.1 DFE Pharma Company Information
6.5.2 DFE Pharma Description and Business Overview
6.5.3 DFE Pharma Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2020-2025)
6.5.4 DFE Pharma Orally Disintegrating Tablet Excipient Product Portfolio
6.5.5 DFE Pharma Recent Developments/Updates
6.6 Evonik
6.6.1 Evonik Company Information
6.6.2 Evonik Description and Business Overview
6.6.3 Evonik Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Evonik Orally Disintegrating Tablet Excipient Product Portfolio
6.6.5 Evonik Recent Developments/Updates
6.7 Merck KGaA
6.7.1 Merck KGaA Company Information
6.7.2 Merck KGaA Description and Business Overview
6.7.3 Merck KGaA Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Merck KGaA Orally Disintegrating Tablet Excipient Product Portfolio
6.7.5 Merck KGaA Recent Developments/Updates
6.8 Ashland
6.8.1 Ashland Company Information
6.8.2 Ashland Description and Business Overview
6.8.3 Ashland Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Ashland Orally Disintegrating Tablet Excipient Product Portfolio
6.8.5 Ashland Recent Developments/Updates
6.9 Meggle Pharma
6.9.1 Meggle Pharma Company Information
6.9.2 Meggle Pharma Description and Business Overview
6.9.3 Meggle Pharma Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Meggle Pharma Orally Disintegrating Tablet Excipient Product Portfolio
6.9.5 Meggle Pharma Recent Developments/Updates
6.10 Shin-Etsu
6.10.1 Shin-Etsu Company Information
6.10.2 Shin-Etsu Description and Business Overview
6.10.3 Shin-Etsu Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Shin-Etsu Orally Disintegrating Tablet Excipient Product Portfolio
6.10.5 Shin-Etsu Recent Developments/Updates
6.11 Fuji Chemical Industries
6.11.1 Fuji Chemical Industries Company Information
6.11.2 Fuji Chemical Industries Description and Business Overview
6.11.3 Fuji Chemical Industries Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Fuji Chemical Industries Orally Disintegrating Tablet Excipient Product Portfolio
6.11.5 Fuji Chemical Industries Recent Developments/Updates
6.12 McePharma (Vivesa holding)
6.12.1 McePharma (Vivesa holding) Company Information
6.12.2 McePharma (Vivesa holding) Description and Business Overview
6.12.3 McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2020-2025)
6.12.4 McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Product Portfolio
6.12.5 McePharma (Vivesa holding) Recent Developments/Updates
6.13 Cargill Incorporated
6.13.1 Cargill Incorporated Company Information
6.13.2 Cargill Incorporated Description and Business Overview
6.13.3 Cargill Incorporated Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Cargill Incorporated Orally Disintegrating Tablet Excipient Product Portfolio
6.13.5 Cargill Incorporated Recent Developments/Updates
6.14 Daicel Corporation
6.14.1 Daicel Corporation Company Information
6.14.2 Daicel Corporation Description and Business Overview
6.14.3 Daicel Corporation Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Daicel Corporation Orally Disintegrating Tablet Excipient Product Portfolio
6.14.5 Daicel Corporation Recent Developments/Updates
6.15 Anhui Sunhere Pharmaceutical
6.15.1 Anhui Sunhere Pharmaceutical Company Information
6.15.2 Anhui Sunhere Pharmaceutical Description and Business Overview
6.15.3 Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Product Portfolio
6.15.5 Anhui Sunhere Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Orally Disintegrating Tablet Excipient Industry Chain Analysis
7.2 Orally Disintegrating Tablet Excipient Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Orally Disintegrating Tablet Excipient Production Mode & Process Analysis
7.4 Orally Disintegrating Tablet Excipient Sales and Marketing
7.4.1 Orally Disintegrating Tablet Excipient Sales Channels
7.4.2 Orally Disintegrating Tablet Excipient Distributors
7.5 Orally Disintegrating Tablet Excipient Customer Analysis
8 Orally Disintegrating Tablet Excipient Market Dynamics
8.1 Orally Disintegrating Tablet Excipient Industry Trends
8.2 Orally Disintegrating Tablet Excipient Market Drivers
8.3 Orally Disintegrating Tablet Excipient Market Challenges
8.4 Orally Disintegrating Tablet Excipient Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Orally Disintegrating Tablet Excipient Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Orally Disintegrating Tablet Excipient Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Orally Disintegrating Tablet Excipient Market Competitive Situation by Manufacturers in 2024
Table 4. Global Orally Disintegrating Tablet Excipient Sales (K MT) of Key Manufacturers (2020-2025)
Table 5. Global Orally Disintegrating Tablet Excipient Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Orally Disintegrating Tablet Excipient Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Orally Disintegrating Tablet Excipient Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Orally Disintegrating Tablet Excipient Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Orally Disintegrating Tablet Excipient, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Orally Disintegrating Tablet Excipient, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Orally Disintegrating Tablet Excipient, Product Type & Application
Table 12. Global Key Manufacturers of Orally Disintegrating Tablet Excipient, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Orally Disintegrating Tablet Excipient by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Orally Disintegrating Tablet Excipient as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Orally Disintegrating Tablet Excipient Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Orally Disintegrating Tablet Excipient Sales by Region (2020-2025) & (K MT)
Table 18. Global Orally Disintegrating Tablet Excipient Sales Market Share by Region (2020-2025)
Table 19. Global Orally Disintegrating Tablet Excipient Sales by Region (2026-2031) & (K MT)
Table 20. Global Orally Disintegrating Tablet Excipient Sales Market Share by Region (2026-2031)
Table 21. Global Orally Disintegrating Tablet Excipient Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Region (2020-2025)
Table 23. Global Orally Disintegrating Tablet Excipient Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Region (2026-2031)
Table 25. North America Orally Disintegrating Tablet Excipient Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Orally Disintegrating Tablet Excipient Sales by Country (2020-2025) & (K MT)
Table 27. North America Orally Disintegrating Tablet Excipient Sales by Country (2026-2031) & (K MT)
Table 28. North America Orally Disintegrating Tablet Excipient Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Orally Disintegrating Tablet Excipient Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Orally Disintegrating Tablet Excipient Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Orally Disintegrating Tablet Excipient Sales by Country (2020-2025) & (K MT)
Table 32. Europe Orally Disintegrating Tablet Excipient Sales by Country (2026-2031) & (K MT)
Table 33. Europe Orally Disintegrating Tablet Excipient Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Orally Disintegrating Tablet Excipient Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Orally Disintegrating Tablet Excipient Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Orally Disintegrating Tablet Excipient Sales by Region (2020-2025) & (K MT)
Table 37. Asia Pacific Orally Disintegrating Tablet Excipient Sales by Region (2026-2031) & (K MT)
Table 38. Asia Pacific Orally Disintegrating Tablet Excipient Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Orally Disintegrating Tablet Excipient Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Orally Disintegrating Tablet Excipient Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Orally Disintegrating Tablet Excipient Sales by Country (2020-2025) & (K MT)
Table 42. Latin America Orally Disintegrating Tablet Excipient Sales by Country (2026-2031) & (K MT)
Table 43. Latin America Orally Disintegrating Tablet Excipient Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Orally Disintegrating Tablet Excipient Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Orally Disintegrating Tablet Excipient Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Orally Disintegrating Tablet Excipient Sales by Country (2020-2025) & (K MT)
Table 47. Middle East and Africa Orally Disintegrating Tablet Excipient Sales by Country (2026-2031) & (K MT)
Table 48. Middle East and Africa Orally Disintegrating Tablet Excipient Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Orally Disintegrating Tablet Excipient Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Orally Disintegrating Tablet Excipient Sales (K MT) by Type (2020-2025)
Table 51. Global Orally Disintegrating Tablet Excipient Sales (K MT) by Type (2026-2031)
Table 52. Global Orally Disintegrating Tablet Excipient Sales Market Share by Type (2020-2025)
Table 53. Global Orally Disintegrating Tablet Excipient Sales Market Share by Type (2026-2031)
Table 54. Global Orally Disintegrating Tablet Excipient Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Orally Disintegrating Tablet Excipient Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Type (2020-2025)
Table 57. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Type (2026-2031)
Table 58. Global Orally Disintegrating Tablet Excipient Price (USD/MT) by Type (2020-2025)
Table 59. Global Orally Disintegrating Tablet Excipient Price (USD/MT) by Type (2026-2031)
Table 60. Global Orally Disintegrating Tablet Excipient Sales (K MT) by Application (2020-2025)
Table 61. Global Orally Disintegrating Tablet Excipient Sales (K MT) by Application (2026-2031)
Table 62. Global Orally Disintegrating Tablet Excipient Sales Market Share by Application (2020-2025)
Table 63. Global Orally Disintegrating Tablet Excipient Sales Market Share by Application (2026-2031)
Table 64. Global Orally Disintegrating Tablet Excipient Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Orally Disintegrating Tablet Excipient Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Application (2020-2025)
Table 67. Global Orally Disintegrating Tablet Excipient Revenue Market Share by Application (2026-2031)
Table 68. Global Orally Disintegrating Tablet Excipient Price (USD/MT) by Application (2020-2025)
Table 69. Global Orally Disintegrating Tablet Excipient Price (USD/MT) by Application (2026-2031)
Table 70. BASF Company Information
Table 71. BASF Description and Business Overview
Table 72. BASF Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 73. BASF Orally Disintegrating Tablet Excipient Product
Table 74. BASF Recent Developments/Updates
Table 75. JRS Pharma Company Information
Table 76. JRS Pharma Description and Business Overview
Table 77. JRS Pharma Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 78. JRS Pharma Orally Disintegrating Tablet Excipient Product
Table 79. JRS Pharma Recent Developments/Updates
Table 80. Roquette Company Information
Table 81. Roquette Description and Business Overview
Table 82. Roquette Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 83. Roquette Orally Disintegrating Tablet Excipient Product
Table 84. Roquette Recent Developments/Updates
Table 85. ABF Ingredients Company Information
Table 86. ABF Ingredients Description and Business Overview
Table 87. ABF Ingredients Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 88. ABF Ingredients Orally Disintegrating Tablet Excipient Product
Table 89. ABF Ingredients Recent Developments/Updates
Table 90. DFE Pharma Company Information
Table 91. DFE Pharma Description and Business Overview
Table 92. DFE Pharma Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 93. DFE Pharma Orally Disintegrating Tablet Excipient Product
Table 94. DFE Pharma Recent Developments/Updates
Table 95. Evonik Company Information
Table 96. Evonik Description and Business Overview
Table 97. Evonik Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 98. Evonik Orally Disintegrating Tablet Excipient Product
Table 99. Evonik Recent Developments/Updates
Table 100. Merck KGaA Company Information
Table 101. Merck KGaA Description and Business Overview
Table 102. Merck KGaA Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 103. Merck KGaA Orally Disintegrating Tablet Excipient Product
Table 104. Merck KGaA Recent Developments/Updates
Table 105. Ashland Company Information
Table 106. Ashland Description and Business Overview
Table 107. Ashland Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 108. Ashland Orally Disintegrating Tablet Excipient Product
Table 109. Ashland Recent Developments/Updates
Table 110. Meggle Pharma Company Information
Table 111. Meggle Pharma Description and Business Overview
Table 112. Meggle Pharma Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 113. Meggle Pharma Orally Disintegrating Tablet Excipient Product
Table 114. Meggle Pharma Recent Developments/Updates
Table 115. Shin-Etsu Company Information
Table 116. Shin-Etsu Description and Business Overview
Table 117. Shin-Etsu Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 118. Shin-Etsu Orally Disintegrating Tablet Excipient Product
Table 119. Shin-Etsu Recent Developments/Updates
Table 120. Fuji Chemical Industries Company Information
Table 121. Fuji Chemical Industries Description and Business Overview
Table 122. Fuji Chemical Industries Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 123. Fuji Chemical Industries Orally Disintegrating Tablet Excipient Product
Table 124. Fuji Chemical Industries Recent Developments/Updates
Table 125. McePharma (Vivesa holding) Company Information
Table 126. McePharma (Vivesa holding) Description and Business Overview
Table 127. McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 128. McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Product
Table 129. McePharma (Vivesa holding) Recent Developments/Updates
Table 130. Cargill Incorporated Company Information
Table 131. Cargill Incorporated Description and Business Overview
Table 132. Cargill Incorporated Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 133. Cargill Incorporated Orally Disintegrating Tablet Excipient Product
Table 134. Cargill Incorporated Recent Developments/Updates
Table 135. Daicel Corporation Company Information
Table 136. Daicel Corporation Description and Business Overview
Table 137. Daicel Corporation Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 138. Daicel Corporation Orally Disintegrating Tablet Excipient Product
Table 139. Daicel Corporation Recent Developments/Updates
Table 140. Anhui Sunhere Pharmaceutical Company Information
Table 141. Anhui Sunhere Pharmaceutical Description and Business Overview
Table 142. Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 143. Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Product
Table 144. Anhui Sunhere Pharmaceutical Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Orally Disintegrating Tablet Excipient Distributors List
Table 148. Orally Disintegrating Tablet Excipient Customers List
Table 149. Orally Disintegrating Tablet Excipient Market Trends
Table 150. Orally Disintegrating Tablet Excipient Market Drivers
Table 151. Orally Disintegrating Tablet Excipient Market Challenges
Table 152. Orally Disintegrating Tablet Excipient Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report
List of Figures
Figure 1. Product Picture of Orally Disintegrating Tablet Excipient
Figure 2. Global Orally Disintegrating Tablet Excipient Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Orally Disintegrating Tablet Excipient Market Share by Type: 2024 & 2031
Figure 4. Binders Product Picture
Figure 5. Glidents Product Picture
Figure 6. Diluents Product Picture
Figure 7. Disintegrants Product Picture
Figure 8. Others Product Picture
Figure 9. Global Orally Disintegrating Tablet Excipient Market Value by Application (2020-2031) & (US$ Million)
Figure 10. Global Orally Disintegrating Tablet Excipient Market Share by Application: 2024 & 2031
Figure 11. Anti-Psychotics Drug
Figure 12. Anti-Epileptics Drug
Figure 13. Others
Figure 14. Global Orally Disintegrating Tablet Excipient Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Orally Disintegrating Tablet Excipient Market Size (2020-2031) & (US$ Million)
Figure 16. Global Orally Disintegrating Tablet Excipient Sales (2020-2031) & (K MT)
Figure 17. Global Orally Disintegrating Tablet Excipient Average Price (USD/MT) & (2020-2031)
Figure 18. Orally Disintegrating Tablet Excipient Report Years Considered
Figure 19. Orally Disintegrating Tablet Excipient Sales Share by Manufacturers in 2024
Figure 20. Global Orally Disintegrating Tablet Excipient Revenue Share by Manufacturers in 2024
Figure 21. Global 5 and 10 Largest Orally Disintegrating Tablet Excipient Players: Market Share by Revenue in Orally Disintegrating Tablet Excipient in 2024
Figure 22. Orally Disintegrating Tablet Excipient Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. Global Orally Disintegrating Tablet Excipient Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 24. North America Orally Disintegrating Tablet Excipient Sales Market Share by Country (2020-2031)
Figure 25. North America Orally Disintegrating Tablet Excipient Revenue Market Share by Country (2020-2031)
Figure 26. U.S. Orally Disintegrating Tablet Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Canada Orally Disintegrating Tablet Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Europe Orally Disintegrating Tablet Excipient Sales Market Share by Country (2020-2031)
Figure 29. Europe Orally Disintegrating Tablet Excipient Revenue Market Share by Country (2020-2031)
Figure 30. Germany Orally Disintegrating Tablet Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. France Orally Disintegrating Tablet Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. U.K. Orally Disintegrating Tablet Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Italy Orally Disintegrating Tablet Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Russia Orally Disintegrating Tablet Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Asia Pacific Orally Disintegrating Tablet Excipient Sales Market Share by Region (2020-2031)
Figure 36. Asia Pacific Orally Disintegrating Tablet Excipient Revenue Market Share by Region (2020-2031)
Figure 37. China Orally Disintegrating Tablet Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Japan Orally Disintegrating Tablet Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. South Korea Orally Disintegrating Tablet Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. India Orally Disintegrating Tablet Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Australia Orally Disintegrating Tablet Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. China Taiwan Orally Disintegrating Tablet Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Indonesia Orally Disintegrating Tablet Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Thailand Orally Disintegrating Tablet Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Malaysia Orally Disintegrating Tablet Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Latin America Orally Disintegrating Tablet Excipient Sales Market Share by Country (2020-2031)
Figure 47. Latin America Orally Disintegrating Tablet Excipient Revenue Market Share by Country (2020-2031)
Figure 48. Mexico Orally Disintegrating Tablet Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Brazil Orally Disintegrating Tablet Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Argentina Orally Disintegrating Tablet Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Middle East and Africa Orally Disintegrating Tablet Excipient Sales Market Share by Country (2020-2031)
Figure 52. Middle East and Africa Orally Disintegrating Tablet Excipient Revenue Market Share by Country (2020-2031)
Figure 53. Turkey Orally Disintegrating Tablet Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Saudi Arabia Orally Disintegrating Tablet Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. UAE Orally Disintegrating Tablet Excipient Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Global Sales Market Share of Orally Disintegrating Tablet Excipient by Type (2020-2031)
Figure 57. Global Revenue Market Share of Orally Disintegrating Tablet Excipient by Type (2020-2031)
Figure 58. Global Orally Disintegrating Tablet Excipient Price (USD/MT) by Type (2020-2031)
Figure 59. Global Sales Market Share of Orally Disintegrating Tablet Excipient by Application (2020-2031)
Figure 60. Global Revenue Market Share of Orally Disintegrating Tablet Excipient by Application (2020-2031)
Figure 61. Global Orally Disintegrating Tablet Excipient Price (USD/MT) by Application (2020-2031)
Figure 62. Orally Disintegrating Tablet Excipient Value Chain
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
